Skip to main content

News and Events

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

169 Results

Filters

Selected Filters

169 Results

RECOVER researchers identify gaps in Long COVID research for older adults

RECOVER researchers analyzed 59 Long COVID research studies to identify gaps in understanding, preventing, diagnosing, and treating Long COVID in older adults.

Feature
Review

RECOVER Representatives and researchers join new advisory committee addressing Long COVID’s impact on public health

Six people who are contributing to RECOVER now also serve on the U.S. Secretary for Health and Human Services’ Advisory Committee on Long COVID, providing recommendations regarding Long COVID and associated conditions.

Feature

A person’s sex may affect their risk of developing Long COVID

Some women taking part in RECOVER research were more likely to experience Long COVID compared to men.

Announcement
Observational Adult

NIH-funded study finds cases of ME/CFS increase following COVID-19 

Results from a recent RECOVER study suggest that adults who have COVID-19 may be more likely to develop a related condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

News Release
Observational Adult

NIH hosts January 10 webinar to discuss RECOVER-TLC’s progress

NIH leaders will provide updates and answer questions about RECOVER’s latest efforts to identify safe and effective treatments for Long COVID.

Announcement
Clinical Trial

R3 Seminar Recap: Persistent SARS-CoV-2 antigens and correlation with Long COVID symptoms: Findings from a multi-cohort study

During the December 10th RECOVER Research Review (R3) Seminar, researchers described a recent pathobiology study investigating viral persistence, or when SARS-CoV-2 remains in a person’s body and continues to cause changes even after they recover from their initial sickness. The study’s findings suggest that viral persistence could be one reason why some people experience certain symptoms of Long COVID.

R3 Seminar Recap
Pathobiology Adult

New insights on Long COVID symptoms in adults highlight update to RECOVER study findings

Data provided by more than 3,800 new study participants reinforce how the long-term effects of COVID-19 can be different for everyone.

Announcement
Observational Adult

Reviewing RECOVER’s impact in 2024

In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.

Feature
Clinical Trial Observational EHR Pathobiology Adult Pediatric Pregnant Women